Form D — Affinia Therapeutics Inc.
0001231919-25-000313 · filed 2025-10-14
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $45,000,000
- Total sold
- $13,268,335
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Affinia Therapeutics Inc.
- CIK
- 1792694
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 43 FOUNDRY AVE, SUITE 120
WALTHAM, MA 02453 - Phone
- 617-430-7817
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rick Modi · Executive OfficerWALTHAM, MA Find on LinkedIn ↗
-
Rami Daoud · Executive OfficerWALTHAM, MA Find on LinkedIn ↗
-
Sean Nolan · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Diana Brainard · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Elliott Sigal · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Edward Mathers · DirectorWALTHAM, MA Find on LinkedIn ↗
-
David Grayzel · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Carole Faig · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Luc Vandenberghe · DirectorWALTHAM, MA Find on LinkedIn ↗
-
Robert Weisskoff · DirectorWALTHAM, MA Find on LinkedIn ↗
View original on SEC EDGAR.